Supercritical fluids processing of recombinant human growth hormone

被引:21
|
作者
Velaga, SP [1 ]
Carlfors, J [1 ]
机构
[1] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden
关键词
supercritical fluids; SEDS; human growth hormone; precipitation; powders; protein; stability;
D O I
10.1081/DDC-200047368
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of the study was to investigate the feasibility of precipitating recombinant human growth hormone (hGH) from aqueous solutions using conventional and modified techniques of solution-enhanced dispersion (SEDS) by supercritical fluids. The study investigated the effect on hGH stability of adding isopropanol either as a cosolvent with the original aqueous protein solution (conventional process) or to the supercritical carbon dioxide before mixing with the aqueous protein solution (modified process). The influence of the addition of sucrose (with or without isopropanol) on the precipitation behavior and stability of the protein was also studied. Experiments were performed under various processing conditions (pressure 100-200 bars and temperature 40-50degreesC), and with various flow rates and solution compositions (CO2/isopropanol and protein solution). Bioanalytical characterization of the resulting powders involved spectrophotometry, sodium dodecyl sulfate-polycrylamide gel electrophoresis, reverse-phase high performance liquid chromatography (RP-HPLC), and size exclusion chromatography. Solid-state characterization was performed using differential scanning calorimetry, X-ray powder diffraction, scanning electron microscopy, and Karl Fischer techniques. Results showed that with both conventional and modified methods, under optimum processing conditions, the presence of sucrose in the solution decreased the destabilizing effects of the solvent and/or process on the structure of hGH. More hGH was dissolved from the precipitated powders containing sucrose than from those containing only isopropanol. Reverse-phase HPLC indicated that about 94% of the hGH was recovered in its native form. The proportion of dimers and oligomers was reduced in the presence of sucrose; about 92% of the soluble protein was present in monomer form under optimal conditions. The remaining undissolved protein was in monomeric form. The precipitated powders were amorphous, containing particulate aggregates in the size range 1-6 mum with 5-10% residual moisture content. In conclusion, hGH was successfully precipitated from aqueous solution using SEDS technology. The presence of sucrose in the protein solution promoted the precipitation of hGH and reduced aggregation and improved dissolution.
引用
收藏
页码:135 / 149
页数:15
相关论文
共 50 条
  • [41] Comparison of the Escherichia coli proteomes for recombinant human growth hormone producing and nonproducing fermentations
    Champion, KM
    Nishihara, JC
    Aldor, IS
    Moreno, GT
    Andersen, D
    Stults, KL
    Vanderlaan, M
    PROTEOMICS, 2003, 3 (07) : 1365 - 1373
  • [42] Human growth hormone production by high cell density fermentation of recombinant Escherichia coli
    Zhang, XW
    Sun, T
    Liu, X
    Gu, DX
    Huang, XN
    PROCESS BIOCHEMISTRY, 1998, 33 (06) : 683 - 686
  • [43] Improved Solubilization of Recombinant Human Growth Hormone Inclusion Body Produced in Escherichia coli
    Sonoda, Hiroyuki
    Sugimura, Atsushi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2008, 72 (10) : 2675 - 2680
  • [44] High throughput purification of recombinant human growth hormone using radial flow chromatography
    Singh, Surinder M.
    Sharma, Aparna
    Panda, Amulya K.
    PROTEIN EXPRESSION AND PURIFICATION, 2009, 68 (01) : 54 - 59
  • [45] Production of recombinant human growth hormone by rCHO cells in a depth filter perfusion system
    Jae Choon Kim
    Hyeong Sun Kwon
    Duk Jae Oh
    Biotechnology and Bioprocess Engineering, 2014, 19 : 1097 - 1104
  • [46] A Reporter Gene Assay for Measuring the Biological Activity of PEGylated Recombinant Human Growth Hormone
    Hu, Shaowang
    Zhang, Xiaoming
    Li, Yi
    Li, Jing
    Wang, Yingwu
    Liang, Chenggang
    MOLECULES, 2025, 30 (03):
  • [47] Mass Spectrometric Analysis of Innovator, Counterfeit, and Follow-On Recombinant Human Growth Hormone
    Jiang, Haitao
    Wu, Shiaw-Lin
    Karger, Barry L.
    Hancock, William S.
    BIOTECHNOLOGY PROGRESS, 2009, 25 (01) : 207 - 218
  • [48] Production of recombinant human growth hormone by rCHO cells in a depth filter perfusion system
    Kim, Jae Choon
    Kwon, Hyeong Sun
    Oh, Duk Jae
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2014, 19 (06) : 1097 - 1104
  • [49] Case Report: Human Recombinant Growth Hormone Therapy in a DSH Cat Presented With Dwarfism
    Naceradska, Martina
    Horackova, Katerina Navojova
    Fridrichova, Michaela
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [50] Transient growth in diabatic boundary layers with fluids at supercritical pressure
    Boldini, Pietro Carlo
    Bugeat, Benjamin
    Peeters, Jurriaan W. R.
    Kloker, Markus
    Pecnik, Rene
    PHYSICAL REVIEW FLUIDS, 2024, 9 (08):